Status:
COMPLETED
Oral Vitamin B12 as Potential Treatment of Recurrent Aphthous Stomatitis
Lead Sponsor:
Soroka University Medical Center
Conditions:
Recurrent Aphthous Stomatitis
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Background: Recurrent aphthous stomatitis is a common phenomenon in Primary Medicine.Frequency of the phenomenon can be as high as 25% of the general population and the recurrence of the problem can ...
Detailed Description
Scientific Background: Recurrent painful canker sores within the mouth (Recurrent aphthous stomatitis, RAS) are a common phenomenon in Primary Medicine (1,2). The term "aphthai" in Greek means a cond...
Eligibility Criteria
Inclusion
- Over 18 years old.
- Suffering from RAS as least for one year with a frequency of at least one sore per month
Exclusion
- Known systemic diseases concurrent with lesions in the mouth (Behcet's disease, jaundice, Rheumatism, Aides).
- Does not speak Hebrew, Russian, or English.
- Patients who have received in the last year Vit. B12 in any form.
- Patients who receive other treatment for RAS.
- Pregnant or nursing mothers.
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
End Date :
January 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00288769
Start Date
March 1 2006
End Date
January 1 2008
Last Update
January 23 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ben-Gurion University of the Negev
Beersheba, Israel